This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The authors considered two extreme scenarios when evaluating the effectiveness because of the substantial loss to follow-up. The more optimistic scenario was when the responders represented the true effect (responders analysis). The most pessimistic case was when there was no change in nonresponders (all study subjects analysis). The outcome measures used in the analysis were: smoking levels (stratified by gender, age groups, and social class distribution) and quit rates; the proportion of the sample who reported that they had seen or heard any advertising or publicity about stopping smoking;
the proportion of individuals aware of the detrimental effects of smoking on immediate and future health; the proportion of individuals who started smoking; and the change in the mean number of cigarettes smoked per day among smokers.
Effectiveness results
At baseline, the smoking rate was 56.8% in the overall sample, 55.4% in men and 59% in women. It was particularly high in young women. There was no indication of any trend associated with social class.
Forty per cent of the sample reported that they had seen or heard any advertising or publicity about stopping smoking.
The majority of smokers appeared to be unaware of any relationship between smoking and ill health. While the smokers showed greater awareness, the majority of them still denied any long-term detrimental effect on health. Only 39% of smokers thought that the risk of smokers becoming ill with heart disease was "a big deal".
At follow-up, in the responders analysis, the reduction in the smoking rate was 6% (95% confidence interval, CI: 0 -14), as 13% (95% CI: 7 -18) of the participants had quit smoking but 6% (95% CI: 2 -11) had started smoking.
In the all study subjects analysis, the reduction in the smoking rate was 3% (95% CI: 0 -6), as 6% (95% CI: 3 -9) of the participants had quit smoking but 3% (95% CI: 1 -5) had started smoking.
Most cessation was obtained in people aged 25 to 34 years, and in people who completed their education after the age of 21.
The analysis of effectiveness used data derived from different sources. The validity of the single study was limited due to the design and the substantial loss to follow-up. In order to overcome possible bias due to loss to follow-up, the authors considered pessimistic and optimistic scenarios for the outcomes associated with patients who could not be contacted after one year. This enhanced the robustness of the analysis as it provided extreme values that could represent different settings. Information on data derived from published studies was not provided. A formal review of the literature does not appear to have been conducted. Further, the reference used for the assumptions about the number of LYG was not provided. However, extensive sensitivity analyses were carried out through Monte Carlo analysis in order to assess reasonable CIs for all estimates.
Validity of estimate of measure of benefit
Two summary benefit measures were used in the analysis. While the rate of one-year quitters was specific to the intervention considered in the study, the use of LYG will permit more extensive comparisons with the benefits of other health care interventions. Both measures were estimated from actual data (one-year quitter rate) or from the literature (LYG). However, the approach to estimating the benefit results was unclear.
